5-(saenta-x8)fluorescein has been researched along with Leukemia, Myeloid, Acute in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belch, AR; Chlumecky, V; Gati, WP; Larratt, LM; Mant, MJ; Paterson, AR; Turner, AR | 1 |
1 review(s) available for 5-(saenta-x8)fluorescein and Leukemia, Myeloid, Acute
| Article | Year |
|---|---|
Es nucleoside transporter content of acute leukemia cells: role in cell sensitivity to cytarabine (araC).
Topics: Acute Disease; Antimetabolites, Antineoplastic; Carrier Proteins; Cytarabine; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Gene Expression; Humans; Leukemia, Myeloid, Acute; Lymphocytes; Membrane Proteins; Microscopy, Confocal; Nucleoside Transport Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Purine Nucleosides | 1998 |